Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
2
# OF OVERLAPPING
HOLDINGS
IHE
43
HOLDINGS
5%
ALSO IN OZEM
OZEM
19
HOLDINGS
11%
ALSO IN IHE
SECTOR DRIFT (IHE minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 25.6% | 18.4% | 18.4% |
|
PFIZER INC | 4.0% | 3.6% | 3.6% |
IHE Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 22.7% |
|
ELI LILLY & CO | 7.2% |
|
MERCK & CO. INC. | 4.5% |
|
VIATRIS, INC. | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% |
|
ROYALTY PHARMA PLC CLASS A | 4.0% |
|
ELANCO ANIMAL HEALTH, INC. | 3.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
ZOETIS INC | 3.0% |
|
CORCEPT THERAPEUTICS INC | 2.6% |
IHE Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -14.2% |
|
VIKING THERAPEUTICS, INC. | -5.8% |
 |
ROCHE HOLDING LTD | -5.4% |
|
ZEALAND PHARMA A/S | -5.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.6% |
|
AMGEN INC | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.3% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
 |
HANMI PHARM CO LTD | -3.1% |